Background illustration for clinical trials search

Paid Clinical Trials Peoria

Discover 227 paid clinical trials in Peoria, Illinois. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

Combination Chemotherapy With or Without Peripheral Stem Cell Transplantation, Radiation Therapy, and/or Surgery in Treating Patients With Ewing's Sarcoma

for
Sarcoma
Location: Peoria IL, Springfield IL, Iowa City IA, Chicago IL,
Sponsor: University of Leicester

Sex: All

Age: 0 - 49

Code: NCT00020566

Phase 3, Recruiting

A Study to Evaluate Finerenone on Clinical Efficacy and Safety in Patients With Heart Failure Who Are Intolerant or Not Eligible for Treatment With Steroidal Mineralocorticoid Receptor Antagonists

for
Heart Failure
Location: Peoria IL, Merrillville IN, Milwaukee WI, Paducah KY,
Sponsor: Colorado Prevention Center

Sex: All

Age: 18+

Code: NCT06033950

Phase 3, Recruiting

A Study to Determine the Efficacy and Safety of Finerenone and SGLT2i in Combination in Hospitalized Patients With Heart Failure (CONFIRMATION-HF)

for
Heart Failure
Location: Peoria IL, Naperville IL, Merrillville IN,
Sponsor: Colorado Prevention Center

Sex: All

Age: 18+

Code: NCT06024746

Phase 3, Recruiting

Phase 1/2 Study of Respiratory Syncytial Virus and Human Metapneumovirus (RSV+HMPV) Vaccine Candidate in Adults 60 Years of Age and Older

for
Respiratory Syncytial Virus Immunization,
Location: Peoria IL, Melrose Park IL, Indianapolis IN,
Sponsor: Sanofi

Sex: All

Age: 60+

Code: NCT07734649

Phase 1, Phase 2, Recruiting

A Study to Determine the Efficacy and Safety of Finerenone on Morbidity and Mortality Among Hospitalized Heart Failure Patients

for
Heart Failure, Acute Heart Failure
Location: Peoria IL, Naperville IL, Merrillville IN, Chicago IL,
Sponsor: Colorado Prevention Center

Sex: All

Age: 18+

Code: NCT06008197

Phase 3, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

A Phase 3 Study of Rezpegaldesleukin (NKTR-358) for Patients ≥ 12 Years of Age With Moderate-to-Severe Atopic Dermatitis

for
Moderate-to-Severe Atopic Dermatitis
Location: Normal IL, Owensboro KY, Bowling Green KY, Omaha NE,
Sponsor: Nektar Therapeutics

Sex: All

Age: 12+

Code: NCT07690371

Phase 3, Recruiting

Efficacy and Safety of Nipent, Cytoxan and Rituxan in the Treatment of Chronic Lymphocytic Leukemia.

for
Chronic Lymphocytic Leukemia
Location: Gurnee IL, Lafayette IN, St. Louis MO, Indianapolis IN,
Sponsor: East Valley Hematology and Oncology Medical Group

Sex: All

Age: 18+

Code: NCT00131313

Recruiting